View Financial HealthZoono Group 배당 및 자사주 매입배당 기준 점검 0/6Zoono Group 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률-8.4%자사주 매입 수익률총 주주 수익률-8.4%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Mar 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 16% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$1.9m free cash flow). Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m (NZ$1.0m revenue, or US$599k). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (AU$27.2m market cap, or US$18.7m).Reported Earnings • Feb 25First half 2026 earnings released: NZ$0.003 loss per share (vs NZ$0.004 loss in 1H 2025)First half 2026 results: NZ$0.003 loss per share (improved from NZ$0.004 loss in 1H 2025). Revenue: NZ$507.6k (down 29% from 1H 2025). Net loss: NZ$1.24m (loss narrowed 6.5% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.New Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NZ$1.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$1.9m free cash flow). Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m (NZ$1.0m revenue, or US$625k). Minor Risk Market cap is less than US$100m (AU$21.5m market cap, or US$15.2m).공고 • Oct 20Zoono Group Limited, Annual General Meeting, Nov 20, 2025Zoono Group Limited, Annual General Meeting, Nov 20, 2025. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000 AustraliaNew Risk • Oct 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 17% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 59% per year over the past 5 years. Revenue is less than US$1m (NZ$1.3m revenue, or US$716k). Minor Risks Share price has been volatile over the past 3 months (17% average weekly change). Market cap is less than US$100m (AU$20.3m market cap, or US$13.1m).Reported Earnings • Aug 29Full year 2025 earnings released: NZ$0.011 loss per share (vs NZ$0.041 loss in FY 2024)Full year 2025 results: NZ$0.011 loss per share (improved from NZ$0.041 loss in FY 2024). Revenue: NZ$1.25m (up 19% from FY 2024). Net loss: NZ$3.93m (loss narrowed 57% from FY 2024). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings.공고 • Aug 28Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,428,730 Price\Range: AUD 0.035 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 28,349,219 Price\Range: AUD 0.035 Transaction Features: Rights Offering공고 • Jun 21Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,776,259 Price\Range: AUD 0.035 Transaction Features: Rights OfferingNew Risk • May 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$2.7m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 57% per year over the past 5 years. Shareholders have been substantially diluted in the past year (66% increase in shares outstanding). Revenue is less than US$1m (NZ$1.1m revenue, or US$659k). Market cap is less than US$10m (AU$12.1m market cap, or US$7.77m).New Risk • Feb 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$3.2m free cash flow). Earnings have declined by 47% per year over the past 5 years. Shareholders have been substantially diluted in the past year (76% increase in shares outstanding). Revenue is less than US$1m (NZ$1.0m revenue, or US$596k). Market cap is less than US$10m (AU$9.95m market cap, or US$6.26m). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change).공고 • Oct 11Zoono Group Limited, Annual General Meeting, Nov 13, 2024Zoono Group Limited, Annual General Meeting, Nov 13, 2024. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000, AustraliaReported Earnings • Aug 22Full year 2024 earnings released: NZ$0.041 loss per share (vs NZ$0.002 loss in FY 2023)Full year 2024 results: NZ$0.041 loss per share (further deteriorated from NZ$0.002 loss in FY 2023). Revenue: NZ$1.05m (down 69% from FY 2023). Net loss: NZ$9.09m (loss widened NZ$8.74m from FY 2023).New Risk • May 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 99% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (28% average weekly change). Earnings have declined by 32% per year over the past 5 years. Shareholders have been substantially diluted in the past year (99% increase in shares outstanding). Market cap is less than US$10m (AU$9.69m market cap, or US$6.46m). Minor Risk Revenue is less than US$5m (NZ$2.1m revenue, or US$1.3m).공고 • May 18Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,574,320 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct ListingReported Earnings • Feb 25First half 2024 earnings released: NZ$0.031 loss per share (vs NZ$0.008 profit in 1H 2023)First half 2024 results: NZ$0.031 loss per share (down from NZ$0.008 profit in 1H 2023). Revenue: NZ$650.4k (down 65% from 1H 2023). Net loss: NZ$5.93m (down NZ$7.30m from profit in 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.공고 • Feb 14Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,000,000 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct ListingNew Risk • Jan 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$9.29m market cap, or US$6.11m). Minor Risks Shareholders have been diluted in the past year (21% increase in shares outstanding). Revenue is less than US$5m (NZ$3.3m revenue, or US$2.0m).공고 • Dec 13+ 1 more updateZoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 66,786,854 Price\Range: AUD 0.027 Transaction Features: Rights Offering공고 • Oct 06Zoono Group Limited, Annual General Meeting, Nov 27, 2023Zoono Group Limited, Annual General Meeting, Nov 27, 2023, at 11:01 AUS Eastern Standard Time.Reported Earnings • Aug 25Full year 2023 earnings released: NZ$0.002 loss per share (vs NZ$0.069 loss in FY 2022)Full year 2023 results: NZ$0.002 loss per share (improved from NZ$0.069 loss in FY 2022). Revenue: NZ$3.34m (down 63% from FY 2022). Net loss: NZ$350.4k (loss narrowed 97% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.New Risk • Jul 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 8.4% per year over the past 5 years. Market cap is less than US$10m (AU$9.69m market cap, or US$6.52m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (14% increase in shares outstanding). Revenue is less than US$5m (NZ$4.8m revenue, or US$3.0m).Reported Earnings • Feb 24First half 2023 earnings released: EPS: NZ$0.008 (vs NZ$0.012 loss in 1H 2022)First half 2023 results: EPS: NZ$0.008 (up from NZ$0.012 loss in 1H 2022). Revenue: NZ$1.85m (down 70% from 1H 2022). Net income: NZ$1.37m (up NZ$3.36m from 1H 2022). Profit margin: 74% (up from net loss in 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 19 percentage points per year, which is a significant difference in performance.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공고 • Oct 25Zoono Group Limited, Annual General Meeting, Nov 25, 2022Zoono Group Limited, Annual General Meeting, Nov 25, 2022, at 10:00 AUS Eastern Standard Time. Location: Conference Room 1, Hall Chadwick Level 40, 2 Park Street Sydney Australia Agenda: To Adopt the Remuneration Report; to consider Election of Mr. Don Clarke; to consider Approval of Issue of Securities under an Employee Incentive Plan; to consider Approval for Additional Share Placement Capacity.공고 • Oct 17Zoono Group Limited Develops New Nasal Spray ProductZoono Group Limited announced the development of the first of its specialty products for use in the clinical, medical and OTC sectors. Over the past 18 months, Zoono has been working closely with the Faculty of Medical and Health Sciences at the University of Auckland, examining the effects of Zoono technology on staphylococcus and pseudomonas biofilms in the laboratory. These pathogens are often detected in patients experiencing sinusitis and can be very resistant to treatment with antibiotics. Chronic rhinosinusitis is a common condition that causes a marked reduction in quality of life for those who suffer from it. This project has been partially funded by a grant from the New Zealand Government Science and Innovation Agency. The University team has been led by Professor Richard Douglas - a specialist ORL surgeon with clinical and research interests in the medical and surgical management of chronic rhinosinusitis. He is a consultant surgeon at Auckland City and Gillies Hospitals and is a Professor of Surgery at the University of Auckland. His project team includes Dr. Brett Wagner-MacKenzie, a research fellow in the Department of Surgery at the University of Auckland. The test results from the product trials completed at the University have exceeded all expectations. The testing confirmed: a significant reduction in viable staphylococcus aureus biofilms at one hour and eradication at six hours; and a significant reduction in viable pseudomonas aeruginosa biofilms at 5 minutes and near eradication within one 1 hour. The new formulation will be sold as a treatment of chronic rhinosinusitis (CRS) - a condition that is estimated to affect 12.3% of the population in the USA, 10.9% in Europe and 13% in China. Zoono is keen to expand its product range into this market as the global inhalation and nasal spray generic drugs market was estimated at USD 17.50 billion in 2021. Further, it is expected to expand at a compound annual growth rate of circa 9% from 2022 to 2030. Another material advantage of the new Zoono product is that it has the potential to substantially reduce the use of antibiotics in the treatment of sinusitis, thereby reducing the potential for the development of antibiotic resistance. The Zoono technology does not promote mutation and pathogens are unable to develop immunity.Reported Earnings • Aug 26Full year 2022 earnings released: NZ$6.82 loss per share (vs NZ$0.029 profit in FY 2021)Full year 2022 results: NZ$6.82 loss per share (down from NZ$0.029 profit in FY 2021). Revenue: NZ$9.02m (down 67% from FY 2021). Net loss: NZ$11.4m (down 341% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 208 percentage points per year, which is a significant difference in performance.분석 기사 • Jun 19Zoono Group (ASX:ZNO) Shareholders Will Want The ROCE Trajectory To ContinueIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공고 • Apr 02Zoono Group Limited Appoints Barry Woolcott as Group Chief Executive OfficerZOONO Group Limited advised the appointment of Mr. Barry Woolcott as Group Chief Executive Officer (CEO). Following an extensive executive search, Mr. Woolcott joined Zoono in September 2021, initially as Global General Manager, with the intention that, at a mutually agreed date, he would assume the role of Chief Executive Officer. Prior to joining Zoono, Mr. Woolcott developed his management capabilities through 7 years at Deloitte and, more recently, 13 years (the last 8 as Group CEO) at Jacobsen Holdings. Importantly for Zoono, Mr. Paul Hyslop will continue to be actively engaged in the business, both as an executive with an emphasis on major customers and new projects and as an on-going member of the Board.분석 기사 • Mar 16Investors Will Want Zoono Group's (ASX:ZNO) Growth In ROCE To PersistWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Buying Opportunity • Jan 24Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be NZ$0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 92% per annum over the last 3 years. Earnings per share has grown by 91% per annum over the last 3 years.분석 기사 • Sep 23Returns On Capital Are A Standout For Zoono Group (ASX:ZNO)What are the early trends we should look for to identify a stock that could multiply in value over the long term...분석 기사 • Sep 02Positive Sentiment Still Eludes Zoono Group Limited (ASX:ZNO) Following 27% Share Price SlumpTo the annoyance of some shareholders, Zoono Group Limited ( ASX:ZNO ) shares are down a considerable 27% in the last...분석 기사 • Aug 31Calculating The Intrinsic Value Of Zoono Group Limited (ASX:ZNO)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Zoono Group Limited...Reported Earnings • Aug 27Full year 2021 earnings released: EPS NZ$0.029 (vs NZ$0.10 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: NZ$27.1m (down 29% from FY 2020). Net income: NZ$4.73m (down 72% from FY 2020). Profit margin: 17% (down from 44% in FY 2020). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 91% per year whereas the company’s share price has increased by 89% per year.Recent Insider Transactions • Jun 12CEO, MD & Director recently sold AU$4.9m worth of stockOn the 3rd of June, Paul Hyslop sold around 7m shares on-market at roughly AU$0.70 per share. This was the largest sale by an insider in the last 3 months. This was Paul's only on-market trade for the last 12 months.공고 • Jun 09STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited acquired 4.% stake in Zoono Group Limited (ASX:ZNO) for AUD 4.9 million.STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited acquired 4.% stake in Zoono Group Limited (ASX:ZNO) for AUD 4.9 million on June 8, 2021. STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited will acquire 2 million and 5 million shares at AUD of 0.7 per share. STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited acquired 4.% stake in Zoono Group Limited (ASX:ZNO) on June 8, 2021.Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improved over the past weekAfter last week's 31% share price gain to NZ$1.06, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 33x in the Chemicals industry in Australia. Total returns to shareholders of 549% over the past three years.분석 기사 • Mar 29Zoono Group Limited (ASX:ZNO) Has Got What It Takes To Be An Attractive Dividend StockIs Zoono Group Limited ( ASX:ZNO ) a good dividend stock? How can we tell? Dividend paying companies with growing...Reported Earnings • Mar 02First half 2021 earnings released: EPS NZ$0.012 (vs NZ$0.004 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: NZ$14.4m (up NZ$12.7m from 1H 2020). Net income: NZ$1.91m (up NZ$2.63m from 1H 2020). Profit margin: 13% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 27New 90-day low: AU$0.67The company is down 52% from its price of AU$1.39 on 27 November 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 8.0% over the same period.공고 • Feb 19Zoono Group Limited to Report First Half, 2021 Results on Feb 25, 2021Zoono Group Limited announced that they will report first half, 2021 results on Feb 25, 2021Is New 90 Day High Low • Feb 10New 90-day low: AU$0.94The company is down 32% from its price of AU$1.38 on 12 November 2020. The Australian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.분석 기사 • Feb 02We're Not So Sure You Should Rely on Zoono Group's (ASX:ZNO) Statutory EarningsStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said that...Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to NZ$1.04, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.4x. This compares to an average P/E of 36x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 197%.Is New 90 Day High Low • Jan 18New 90-day low: AU$1.27The company is down 14% from its price of AU$1.47 on 20 October 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.분석 기사 • Jan 11What Kind Of Shareholders Hold The Majority In Zoono Group Limited's (ASX:ZNO) Shares?The big shareholder groups in Zoono Group Limited ( ASX:ZNO ) have power over the company. Generally speaking, as a...분석 기사 • Dec 23Did You Miss Zoono Group's (ASX:ZNO) Impressive 235% Share Price Gain?While Zoono Group Limited ( ASX:ZNO ) shareholders are probably generally happy, the stock hasn't had particularly good...Is New 90 Day High Low • Dec 11New 90-day low: AU$1.31The company is down 39% from its price of AU$2.16 on 11 September 2020. The Australian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period.분석 기사 • Dec 01How Should Investors React To Zoono Group's (ASX:ZNO) CEO Pay?The CEO of Zoono Group Limited ( ASX:ZNO ) is Paul Hyslop, and this article examines the executive's compensation...Valuation Update With 7 Day Price Move • Nov 03Market bids up stock over the past weekAfter last week's 20% share price gain to NZ$1.58, the stock is trading at a trailing P/E ratio of 16.5x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 18x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 269%.Valuation Update With 7 Day Price Move • Oct 16Market pulls back on stock over the past weekAfter last week's 22% share price decline to NZ$1.44, the stock is trading at a trailing P/E ratio of 15.1x, down from the previous P/E ratio of 19.3x. This compares to an average P/E of 19x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 197%.Is New 90 Day High Low • Oct 15New 90-day low: AU$1.55The company is down 35% from its price of AU$2.38 on 17 July 2020. The Australian market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period.Is New 90 Day High Low • Sep 29New 90-day low: AU$1.79The company is down 37% from its price of AU$2.82 on 01 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.공고 • Sep 22Zoono Group Limited Provides Updates on Legal DisputesZoono Group Limited provided updates on legal disputes. Zoono takes a strong line on its Distribution Agreements. Its policy is that distributors must meet minimum sales obligations (as set out in their respective agreements) and, if they are unable to do so, face termination for non- performance. As a result of this policy, Zoono is now involved in two disputes involving legal proceedings in New Zealand. Zoono is in dispute with China based Qingdao Zoono Biotechnology Company Limited (QZB) in relation to the termination of its Distribution Agreement. Zoono does not believe there is any merit in QZB's claim. Currently, as QZB has failed to make payments ordered by the NZ Courts, its application is stayed until such payments are made. If non-payment continues, Zoono will apply to have the claim dismissed. The second dispute relates to Zoono's termination of its Distribution Agreement with UAE based Sky Scrapers General Trading LLC (SSGT). Zoono has been advised by SSGT that it intends to initiate court proceedings seeking to have the Distribution Agreement reinstated. If it does so, Zoono intends to file a counter claim for damages for breach of that agreement. Zoono is also confident of success in this dispute. While it is unfortunate that Zoono is involved in these disputes, nothing will deter Zoono from taking what it regards as reasonable and appropriate steps to protect its business interests.공고 • Sep 17United Airlines Adds Zoono Group Limited's Antimicrobial Spray to Already Extensive Cabin-Cleaning MeasuresUnited Airlines announced that it is adding Zoono Microbe Shield, an EPA registered antimicrobial coating that forms a long-lasting bond with surfaces and inhibits the growth of microbes, to the airline's already rigorous safety and cleaning procedures. United is currently applying the coating each week on more than 30 aircraft to seats, tray tables, armrests, overhead bins, lavatories and crew stations and expects to add this latest measure to its entire mainline and express fleet before the end of the year. The antimicrobial coating, created by Zoono Group Limited will serve as an added layer of protection that complements the airline's existing, daily electrostatic spraying regimen before departing flights. The Zoono Microbe Shield works by bonding to surfaces and creating a protective layer that resembles microscopic pins once dry which rupture cell walls and membranes when microbes come in contact with them. The chemical is classified by the EPA as Category IV, which is the lowest level of toxicity. During an aircraft's deep cleanings, United will use the NovaRover which is designed to apply a super fine mist of the antimicrobial that coats all surfaces in a 12-foot radius with a single spray. United will apply the antimicrobial to aircraft overnight every seven days using electrostatic sprayers to refresh and fortify the protective layer, while continuing to electrostatic spray disinfectant to the aircraft cabin before almost every departure. United is currently applying Zoono Microbe Shield on aircraft at Chicago O'Hare International Airport and expects to expand it to each of its six other hubs and approximately 200 U.S. airports where United aircraft remain overnight in the coming months. The airline plans to deploy NovaRovers at ten airports, including each of United's seven hubs as well as Boston, Cleveland and Las Vegas.공고 • Aug 12Zoono Group Limited to Report Fiscal Year 2020 Results on Aug 20, 2020Zoono Group Limited announced that they will report fiscal year 2020 results at 6:00 AM, GMT Standard Time on Aug 20, 2020분석 기사 • Jul 27How Much Are Zoono Group Limited (ASX:ZNO) Insiders Taking Off The Table?It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...분석 기사 • Jun 30A Look At The Fair Value Of Zoono Group Limited (ASX:ZNO)Today we will run through one way of estimating the intrinsic value of Zoono Group Limited (ASX:ZNO) by projecting its...지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ZNO 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ZNO 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Zoono Group 배당 수익률 vs 시장ZNO의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ZNO)0%시장 하위 25% (AU)2.6%시장 상위 25% (AU)6.6%업계 평균 (Chemicals)2.1%분석가 예측 (ZNO) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ZNO 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ZNO 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: ZNO Australian 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: ZNO 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YAU 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/01 04:41종가2026/07/31 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Zoono Group Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • Mar 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 16% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$1.9m free cash flow). Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m (NZ$1.0m revenue, or US$599k). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (AU$27.2m market cap, or US$18.7m).
Reported Earnings • Feb 25First half 2026 earnings released: NZ$0.003 loss per share (vs NZ$0.004 loss in 1H 2025)First half 2026 results: NZ$0.003 loss per share (improved from NZ$0.004 loss in 1H 2025). Revenue: NZ$507.6k (down 29% from 1H 2025). Net loss: NZ$1.24m (loss narrowed 6.5% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
New Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NZ$1.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$1.9m free cash flow). Earnings have declined by 42% per year over the past 5 years. Revenue is less than US$1m (NZ$1.0m revenue, or US$625k). Minor Risk Market cap is less than US$100m (AU$21.5m market cap, or US$15.2m).
공고 • Oct 20Zoono Group Limited, Annual General Meeting, Nov 20, 2025Zoono Group Limited, Annual General Meeting, Nov 20, 2025. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000 Australia
New Risk • Oct 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 17% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 59% per year over the past 5 years. Revenue is less than US$1m (NZ$1.3m revenue, or US$716k). Minor Risks Share price has been volatile over the past 3 months (17% average weekly change). Market cap is less than US$100m (AU$20.3m market cap, or US$13.1m).
Reported Earnings • Aug 29Full year 2025 earnings released: NZ$0.011 loss per share (vs NZ$0.041 loss in FY 2024)Full year 2025 results: NZ$0.011 loss per share (improved from NZ$0.041 loss in FY 2024). Revenue: NZ$1.25m (up 19% from FY 2024). Net loss: NZ$3.93m (loss narrowed 57% from FY 2024). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings.
공고 • Aug 28Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,428,730 Price\Range: AUD 0.035 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 28,349,219 Price\Range: AUD 0.035 Transaction Features: Rights Offering
공고 • Jun 21Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,776,259 Price\Range: AUD 0.035 Transaction Features: Rights Offering
New Risk • May 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$2.7m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 57% per year over the past 5 years. Shareholders have been substantially diluted in the past year (66% increase in shares outstanding). Revenue is less than US$1m (NZ$1.1m revenue, or US$659k). Market cap is less than US$10m (AU$12.1m market cap, or US$7.77m).
New Risk • Feb 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NZ$3.2m free cash flow). Earnings have declined by 47% per year over the past 5 years. Shareholders have been substantially diluted in the past year (76% increase in shares outstanding). Revenue is less than US$1m (NZ$1.0m revenue, or US$596k). Market cap is less than US$10m (AU$9.95m market cap, or US$6.26m). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change).
공고 • Oct 11Zoono Group Limited, Annual General Meeting, Nov 13, 2024Zoono Group Limited, Annual General Meeting, Nov 13, 2024. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000, Australia
Reported Earnings • Aug 22Full year 2024 earnings released: NZ$0.041 loss per share (vs NZ$0.002 loss in FY 2023)Full year 2024 results: NZ$0.041 loss per share (further deteriorated from NZ$0.002 loss in FY 2023). Revenue: NZ$1.05m (down 69% from FY 2023). Net loss: NZ$9.09m (loss widened NZ$8.74m from FY 2023).
New Risk • May 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 99% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (28% average weekly change). Earnings have declined by 32% per year over the past 5 years. Shareholders have been substantially diluted in the past year (99% increase in shares outstanding). Market cap is less than US$10m (AU$9.69m market cap, or US$6.46m). Minor Risk Revenue is less than US$5m (NZ$2.1m revenue, or US$1.3m).
공고 • May 18Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,574,320 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct Listing
Reported Earnings • Feb 25First half 2024 earnings released: NZ$0.031 loss per share (vs NZ$0.008 profit in 1H 2023)First half 2024 results: NZ$0.031 loss per share (down from NZ$0.008 profit in 1H 2023). Revenue: NZ$650.4k (down 65% from 1H 2023). Net loss: NZ$5.93m (down NZ$7.30m from profit in 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.
공고 • Feb 14Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,000,000 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct Listing
New Risk • Jan 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$9.29m market cap, or US$6.11m). Minor Risks Shareholders have been diluted in the past year (21% increase in shares outstanding). Revenue is less than US$5m (NZ$3.3m revenue, or US$2.0m).
공고 • Dec 13+ 1 more updateZoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 66,786,854 Price\Range: AUD 0.027 Transaction Features: Rights Offering
공고 • Oct 06Zoono Group Limited, Annual General Meeting, Nov 27, 2023Zoono Group Limited, Annual General Meeting, Nov 27, 2023, at 11:01 AUS Eastern Standard Time.
Reported Earnings • Aug 25Full year 2023 earnings released: NZ$0.002 loss per share (vs NZ$0.069 loss in FY 2022)Full year 2023 results: NZ$0.002 loss per share (improved from NZ$0.069 loss in FY 2022). Revenue: NZ$3.34m (down 63% from FY 2022). Net loss: NZ$350.4k (loss narrowed 97% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.
New Risk • Jul 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 8.4% per year over the past 5 years. Market cap is less than US$10m (AU$9.69m market cap, or US$6.52m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (14% increase in shares outstanding). Revenue is less than US$5m (NZ$4.8m revenue, or US$3.0m).
Reported Earnings • Feb 24First half 2023 earnings released: EPS: NZ$0.008 (vs NZ$0.012 loss in 1H 2022)First half 2023 results: EPS: NZ$0.008 (up from NZ$0.012 loss in 1H 2022). Revenue: NZ$1.85m (down 70% from 1H 2022). Net income: NZ$1.37m (up NZ$3.36m from 1H 2022). Profit margin: 74% (up from net loss in 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 19 percentage points per year, which is a significant difference in performance.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공고 • Oct 25Zoono Group Limited, Annual General Meeting, Nov 25, 2022Zoono Group Limited, Annual General Meeting, Nov 25, 2022, at 10:00 AUS Eastern Standard Time. Location: Conference Room 1, Hall Chadwick Level 40, 2 Park Street Sydney Australia Agenda: To Adopt the Remuneration Report; to consider Election of Mr. Don Clarke; to consider Approval of Issue of Securities under an Employee Incentive Plan; to consider Approval for Additional Share Placement Capacity.
공고 • Oct 17Zoono Group Limited Develops New Nasal Spray ProductZoono Group Limited announced the development of the first of its specialty products for use in the clinical, medical and OTC sectors. Over the past 18 months, Zoono has been working closely with the Faculty of Medical and Health Sciences at the University of Auckland, examining the effects of Zoono technology on staphylococcus and pseudomonas biofilms in the laboratory. These pathogens are often detected in patients experiencing sinusitis and can be very resistant to treatment with antibiotics. Chronic rhinosinusitis is a common condition that causes a marked reduction in quality of life for those who suffer from it. This project has been partially funded by a grant from the New Zealand Government Science and Innovation Agency. The University team has been led by Professor Richard Douglas - a specialist ORL surgeon with clinical and research interests in the medical and surgical management of chronic rhinosinusitis. He is a consultant surgeon at Auckland City and Gillies Hospitals and is a Professor of Surgery at the University of Auckland. His project team includes Dr. Brett Wagner-MacKenzie, a research fellow in the Department of Surgery at the University of Auckland. The test results from the product trials completed at the University have exceeded all expectations. The testing confirmed: a significant reduction in viable staphylococcus aureus biofilms at one hour and eradication at six hours; and a significant reduction in viable pseudomonas aeruginosa biofilms at 5 minutes and near eradication within one 1 hour. The new formulation will be sold as a treatment of chronic rhinosinusitis (CRS) - a condition that is estimated to affect 12.3% of the population in the USA, 10.9% in Europe and 13% in China. Zoono is keen to expand its product range into this market as the global inhalation and nasal spray generic drugs market was estimated at USD 17.50 billion in 2021. Further, it is expected to expand at a compound annual growth rate of circa 9% from 2022 to 2030. Another material advantage of the new Zoono product is that it has the potential to substantially reduce the use of antibiotics in the treatment of sinusitis, thereby reducing the potential for the development of antibiotic resistance. The Zoono technology does not promote mutation and pathogens are unable to develop immunity.
Reported Earnings • Aug 26Full year 2022 earnings released: NZ$6.82 loss per share (vs NZ$0.029 profit in FY 2021)Full year 2022 results: NZ$6.82 loss per share (down from NZ$0.029 profit in FY 2021). Revenue: NZ$9.02m (down 67% from FY 2021). Net loss: NZ$11.4m (down 341% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 208 percentage points per year, which is a significant difference in performance.
분석 기사 • Jun 19Zoono Group (ASX:ZNO) Shareholders Will Want The ROCE Trajectory To ContinueIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공고 • Apr 02Zoono Group Limited Appoints Barry Woolcott as Group Chief Executive OfficerZOONO Group Limited advised the appointment of Mr. Barry Woolcott as Group Chief Executive Officer (CEO). Following an extensive executive search, Mr. Woolcott joined Zoono in September 2021, initially as Global General Manager, with the intention that, at a mutually agreed date, he would assume the role of Chief Executive Officer. Prior to joining Zoono, Mr. Woolcott developed his management capabilities through 7 years at Deloitte and, more recently, 13 years (the last 8 as Group CEO) at Jacobsen Holdings. Importantly for Zoono, Mr. Paul Hyslop will continue to be actively engaged in the business, both as an executive with an emphasis on major customers and new projects and as an on-going member of the Board.
분석 기사 • Mar 16Investors Will Want Zoono Group's (ASX:ZNO) Growth In ROCE To PersistWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Buying Opportunity • Jan 24Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be NZ$0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 92% per annum over the last 3 years. Earnings per share has grown by 91% per annum over the last 3 years.
분석 기사 • Sep 23Returns On Capital Are A Standout For Zoono Group (ASX:ZNO)What are the early trends we should look for to identify a stock that could multiply in value over the long term...
분석 기사 • Sep 02Positive Sentiment Still Eludes Zoono Group Limited (ASX:ZNO) Following 27% Share Price SlumpTo the annoyance of some shareholders, Zoono Group Limited ( ASX:ZNO ) shares are down a considerable 27% in the last...
분석 기사 • Aug 31Calculating The Intrinsic Value Of Zoono Group Limited (ASX:ZNO)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Zoono Group Limited...
Reported Earnings • Aug 27Full year 2021 earnings released: EPS NZ$0.029 (vs NZ$0.10 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: NZ$27.1m (down 29% from FY 2020). Net income: NZ$4.73m (down 72% from FY 2020). Profit margin: 17% (down from 44% in FY 2020). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 91% per year whereas the company’s share price has increased by 89% per year.
Recent Insider Transactions • Jun 12CEO, MD & Director recently sold AU$4.9m worth of stockOn the 3rd of June, Paul Hyslop sold around 7m shares on-market at roughly AU$0.70 per share. This was the largest sale by an insider in the last 3 months. This was Paul's only on-market trade for the last 12 months.
공고 • Jun 09STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited acquired 4.% stake in Zoono Group Limited (ASX:ZNO) for AUD 4.9 million.STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited acquired 4.% stake in Zoono Group Limited (ASX:ZNO) for AUD 4.9 million on June 8, 2021. STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited will acquire 2 million and 5 million shares at AUD of 0.7 per share. STERLING INVESTMENT MANAGEMENT and Regal Funds Management Pty Limited acquired 4.% stake in Zoono Group Limited (ASX:ZNO) on June 8, 2021.
Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improved over the past weekAfter last week's 31% share price gain to NZ$1.06, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 33x in the Chemicals industry in Australia. Total returns to shareholders of 549% over the past three years.
분석 기사 • Mar 29Zoono Group Limited (ASX:ZNO) Has Got What It Takes To Be An Attractive Dividend StockIs Zoono Group Limited ( ASX:ZNO ) a good dividend stock? How can we tell? Dividend paying companies with growing...
Reported Earnings • Mar 02First half 2021 earnings released: EPS NZ$0.012 (vs NZ$0.004 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: NZ$14.4m (up NZ$12.7m from 1H 2020). Net income: NZ$1.91m (up NZ$2.63m from 1H 2020). Profit margin: 13% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 27New 90-day low: AU$0.67The company is down 52% from its price of AU$1.39 on 27 November 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 8.0% over the same period.
공고 • Feb 19Zoono Group Limited to Report First Half, 2021 Results on Feb 25, 2021Zoono Group Limited announced that they will report first half, 2021 results on Feb 25, 2021
Is New 90 Day High Low • Feb 10New 90-day low: AU$0.94The company is down 32% from its price of AU$1.38 on 12 November 2020. The Australian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
분석 기사 • Feb 02We're Not So Sure You Should Rely on Zoono Group's (ASX:ZNO) Statutory EarningsStatistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said that...
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to NZ$1.04, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.4x. This compares to an average P/E of 36x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 197%.
Is New 90 Day High Low • Jan 18New 90-day low: AU$1.27The company is down 14% from its price of AU$1.47 on 20 October 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.
분석 기사 • Jan 11What Kind Of Shareholders Hold The Majority In Zoono Group Limited's (ASX:ZNO) Shares?The big shareholder groups in Zoono Group Limited ( ASX:ZNO ) have power over the company. Generally speaking, as a...
분석 기사 • Dec 23Did You Miss Zoono Group's (ASX:ZNO) Impressive 235% Share Price Gain?While Zoono Group Limited ( ASX:ZNO ) shareholders are probably generally happy, the stock hasn't had particularly good...
Is New 90 Day High Low • Dec 11New 90-day low: AU$1.31The company is down 39% from its price of AU$2.16 on 11 September 2020. The Australian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period.
분석 기사 • Dec 01How Should Investors React To Zoono Group's (ASX:ZNO) CEO Pay?The CEO of Zoono Group Limited ( ASX:ZNO ) is Paul Hyslop, and this article examines the executive's compensation...
Valuation Update With 7 Day Price Move • Nov 03Market bids up stock over the past weekAfter last week's 20% share price gain to NZ$1.58, the stock is trading at a trailing P/E ratio of 16.5x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 18x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 269%.
Valuation Update With 7 Day Price Move • Oct 16Market pulls back on stock over the past weekAfter last week's 22% share price decline to NZ$1.44, the stock is trading at a trailing P/E ratio of 15.1x, down from the previous P/E ratio of 19.3x. This compares to an average P/E of 19x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 197%.
Is New 90 Day High Low • Oct 15New 90-day low: AU$1.55The company is down 35% from its price of AU$2.38 on 17 July 2020. The Australian market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period.
Is New 90 Day High Low • Sep 29New 90-day low: AU$1.79The company is down 37% from its price of AU$2.82 on 01 July 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
공고 • Sep 22Zoono Group Limited Provides Updates on Legal DisputesZoono Group Limited provided updates on legal disputes. Zoono takes a strong line on its Distribution Agreements. Its policy is that distributors must meet minimum sales obligations (as set out in their respective agreements) and, if they are unable to do so, face termination for non- performance. As a result of this policy, Zoono is now involved in two disputes involving legal proceedings in New Zealand. Zoono is in dispute with China based Qingdao Zoono Biotechnology Company Limited (QZB) in relation to the termination of its Distribution Agreement. Zoono does not believe there is any merit in QZB's claim. Currently, as QZB has failed to make payments ordered by the NZ Courts, its application is stayed until such payments are made. If non-payment continues, Zoono will apply to have the claim dismissed. The second dispute relates to Zoono's termination of its Distribution Agreement with UAE based Sky Scrapers General Trading LLC (SSGT). Zoono has been advised by SSGT that it intends to initiate court proceedings seeking to have the Distribution Agreement reinstated. If it does so, Zoono intends to file a counter claim for damages for breach of that agreement. Zoono is also confident of success in this dispute. While it is unfortunate that Zoono is involved in these disputes, nothing will deter Zoono from taking what it regards as reasonable and appropriate steps to protect its business interests.
공고 • Sep 17United Airlines Adds Zoono Group Limited's Antimicrobial Spray to Already Extensive Cabin-Cleaning MeasuresUnited Airlines announced that it is adding Zoono Microbe Shield, an EPA registered antimicrobial coating that forms a long-lasting bond with surfaces and inhibits the growth of microbes, to the airline's already rigorous safety and cleaning procedures. United is currently applying the coating each week on more than 30 aircraft to seats, tray tables, armrests, overhead bins, lavatories and crew stations and expects to add this latest measure to its entire mainline and express fleet before the end of the year. The antimicrobial coating, created by Zoono Group Limited will serve as an added layer of protection that complements the airline's existing, daily electrostatic spraying regimen before departing flights. The Zoono Microbe Shield works by bonding to surfaces and creating a protective layer that resembles microscopic pins once dry which rupture cell walls and membranes when microbes come in contact with them. The chemical is classified by the EPA as Category IV, which is the lowest level of toxicity. During an aircraft's deep cleanings, United will use the NovaRover which is designed to apply a super fine mist of the antimicrobial that coats all surfaces in a 12-foot radius with a single spray. United will apply the antimicrobial to aircraft overnight every seven days using electrostatic sprayers to refresh and fortify the protective layer, while continuing to electrostatic spray disinfectant to the aircraft cabin before almost every departure. United is currently applying Zoono Microbe Shield on aircraft at Chicago O'Hare International Airport and expects to expand it to each of its six other hubs and approximately 200 U.S. airports where United aircraft remain overnight in the coming months. The airline plans to deploy NovaRovers at ten airports, including each of United's seven hubs as well as Boston, Cleveland and Las Vegas.
공고 • Aug 12Zoono Group Limited to Report Fiscal Year 2020 Results on Aug 20, 2020Zoono Group Limited announced that they will report fiscal year 2020 results at 6:00 AM, GMT Standard Time on Aug 20, 2020
분석 기사 • Jul 27How Much Are Zoono Group Limited (ASX:ZNO) Insiders Taking Off The Table?It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
분석 기사 • Jun 30A Look At The Fair Value Of Zoono Group Limited (ASX:ZNO)Today we will run through one way of estimating the intrinsic value of Zoono Group Limited (ASX:ZNO) by projecting its...